Literature DB >> 23736541

Effects of transaldolase exchange on estimates of gluconeogenesis in type 2 diabetes.

Aman Rajpal1, Simmi Dube, Filipa Carvalho, Ana Rita Simoes, Angelo Figueiredo, Ananda Basu, John Jones, Rita Basu.   

Abstract

Transaldolase (TA) exchange overestimates gluconeogenesis measured with deuterated water (²H₂O). However, it is unknown whether TA differs in people with type 2 diabetes (T2DM). ²H₂O was ingested, and [1-¹³C]acetate and [3-³H]glucose were infused in T2DM (n = 10) and healthy nondiabetic (ND; n = 8) subjects. TA was assessed from the ratio of ¹³C3 to ¹³C4 glucose enrichment (¹³C3/¹³C4) measured by ¹³C NMR. Glucose turnover was measured before (~16-h fast) and during hyperglycemic (~10 mM) moderate-dose insulin (~0.35 mU·kg⁻¹·min⁻¹) clamp. ¹³C3/¹³C4 in T2DM vs. ND was <1.0 and not different at baseline and clamp, indicating equivalent TA. To determine whether incomplete triose phosphate isomerase (TPI) exchange contributed to asymmetric ¹³C3/¹³C4, [U-¹³C]glycerol was infused in lieu of [1-¹³C]acetate during a separate visit in a subset of ND (n = 7) subjects. Ratio of ¹³C3/¹³C4 obtained following either tracer was <1.0 at baseline and during clamp, indicating that TPI exchange was essentially complete and did not contribute to asymmetric glucose enrichment. Uncorrected and corrected rates of gluconeogenesis were no different (P = not significant) in T2DM vs. ND both at baseline and during clamp. TA correction resulted in equivalent estimates of corrected gluconeogenesis in T2DM and ND that were ~25-35% lower than uncorrected gluconeogenesis both at baseline and during the clamp. The asymmetric enrichment of glucose from ¹³C-gluconeogenic tracers is attributable to TA exchange and can be utilized to correct for TA exchange. In conclusion, TA exchange does not differ between T2DM and ND under fasting or hyperglycemic clamp conditions, and the ²H₂O method continues to provide an accurate estimation of gluconeogenesis.

Entities:  

Keywords:  deuterated water; gluconeogenesis; transaldolase; triose phosphate isomerase

Mesh:

Substances:

Year:  2013        PMID: 23736541      PMCID: PMC3891223          DOI: 10.1152/ajpendo.00245.2013

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  27 in total

1.  An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans.

Authors:  J G Jones; M A Solomon; S M Cole; A D Sherry; C R Malloy
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-10       Impact factor: 4.310

2.  Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

Authors:  A Gastaldelli; E Toschi; M Pettiti; S Frascerra; A Quiñones-Galvan; A M Sironi; A Natali; E Ferrannini
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

Authors:  M Roden; H Stingl; V Chandramouli; W C Schumann; A Hofer; B R Landau; P Nowotny; W Waldhäusl; G I Shulman
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

4.  Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity.

Authors:  A Basu; R Basu; P Shah; A Vella; C M Johnson; M Jensen; K S Nair; W F Schwenk; R A Rizza
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

5.  Mechanism by which metformin reduces glucose production in type 2 diabetes.

Authors:  R S Hundal; M Krssak; S Dufour; D Laurent; V Lebon; V Chandramouli; S E Inzucchi; W C Schumann; K F Petersen; B R Landau; G I Shulman
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

6.  Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.

Authors:  G Boden; X Chen; T P Stein
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-01       Impact factor: 4.310

7.  Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus.

Authors:  A Wajngot; V Chandramouli; W C Schumann; K Ekberg; P K Jones; S Efendic; B R Landau
Journal:  Metabolism       Date:  2001-01       Impact factor: 8.694

8.  Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.

Authors:  G Boden; X Chen; E Capulong; M Mozzoli
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

9.  Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.

Authors:  Rita Basu; Cristina Barosa; John Jones; Simmi Dube; Rickey Carter; Ananda Basu; Robert A Rizza
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

10.  Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans.

Authors:  Aron Adkins; Rita Basu; Mai Persson; Betty Dicke; Pankaj Shah; Adrian Vella; W Frederick Schwenk; Robert Rizza
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

View more
  3 in total

Review 1.  Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.

Authors:  Douglas J Morrison; Tom Preston
Journal:  Gut Microbes       Date:  2016-03-10

2.  Novel Insights Into Effects of Cortisol and Glucagon on Nocturnal Glucose Production in Type 2 Diabetes.

Authors:  Ananda Basu; Yogesh Yadav; Rickey E Carter; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

Review 3.  Measurements of Gluconeogenesis and Glycogenolysis: A Methodological Review.

Authors:  Stephanie T Chung; Shaji K Chacko; Agneta L Sunehag; Morey W Haymond
Journal:  Diabetes       Date:  2015-12       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.